Edwards Lifesciences (EW) Other Working Capital Changes (2009 - 2026)

Edwards Lifesciences has reported Other Working Capital Changes for 18 years, with the latest figure at -$29.5 million in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 312.23% year-over-year to -$29.5 million in Q2 2026; TTM through Jun 2026 was -$400000.0, a 101.93% decrease from a year earlier, with the FY2025 full-year figure at $23.7 million, up 204.41% from the prior year.
• Other Working Capital Changes was -$29.5 million for Q2 2026 at Edwards Lifesciences, down from $8.7 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $28.6 million in Q1 2025, with the low at -$6.2 million in Q1 2023.
• Average Other Working Capital Changes over 5 years is $7.6 million, with a median of $5.7 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes slumped 313.79% in 2022, then surged 1500.0% in 2023.
• Over 5 years, Other Working Capital Changes stood at $20.2 million in 2022, then dropped by 10.4% to $18.1 million in 2023, then slumped by 74.03% to $4.7 million in 2024, then surged by 31.91% to $6.2 million in 2025, then slumped by 575.81% to -$29.5 million in 2026.
• The last three Other Working Capital Changes figures came in at -$29.5 million (Q2 2026), $8.7 million (Q1 2026), and $6.2 million (Q4 2025), per Business Quant data.